|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Avenue Therapeutics (NASDAQ: ATXI) through any online brokerage.
There are no as such competitors for Avenue Therapeutics.
The latest price target for Avenue Therapeutics (NASDAQ: ATXI) was reported by HC Wainwright & Co. on 2020-05-12. The analyst firm set a price target for 13.00 expecting ATXI to rise to within 12 months (a possible 172.54% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Avenue Therapeutics (NASDAQ: ATXI) is $4.77 last updated Today at 8:00:02 PM.
There are no upcoming dividends for Avenue Therapeutics.
There is no upcoming split for Avenue Therapeutics.